Page last updated: 2024-11-05

cn 100 and Anasarca

cn 100 has been researched along with Anasarca in 4 studies

CN 100: structure given in first source

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, M1
Masaki, M1
Nohira, H1
Tsurumi, K3
Kyuki, K2
Niwa, M1
Kokuba, S2
Fujimura, H3
Okada, K1
Yanagihara, M2
Hasegawa, J1

Other Studies

4 other studies available for cn 100 and Anasarca

ArticleYear
Optical resolution and absolute configuration of a nonsteroidal antiinflammatory drug, 2-(10,11-dihydro-10-oxodibenzo- [b,f]thiepin-2-yl)propionic acid.
    Chirality, 1990, Volume: 2, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzothiepins; Dogs; Edema; Models, Molecular; Mol

1990
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 1st communication: inhibitory effects of rat paw edema.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:12

    Topics: Adrenalectomy; Animals; Anti-Inflammatory Agents; Benzopyrans; Benzothiepins; Edema; Indomethacin; M

1986
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Benzopyrans; Benzothiepins; B

1986
Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 5th communication: antiplatelet effect of the drug and antiinflammatory effect of its main metabolite.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Benzothiepins; Biotransformation; Blood Platelets; Diarrhea; Edem

1986